NCT00378209 Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00378105 Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT00375791 Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00366106 Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00344526 Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis Status COMPLETED Phase PHASE3
NCT00343863 Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer Status COMPLETED Phase NA
NCT00343460 APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer Status COMPLETED Phase PHASE3
NCT00343369 Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia Status UNKNOWN Phase NA
NCT00337506 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00335348 Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse Status COMPLETED Phase PHASE2
NCT00335140 Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Status TERMINATED Phase PHASE2
NCT00334672 Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis Status UNKNOWN Phase PHASE3
NCT00333996 A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis Status TERMINATED Phase PHASE2/PHASE3
NCT00333814 A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis Status COMPLETED Phase PHASE2/PHASE3
NCT00324467 Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment Status UNKNOWN Phase PHASE2
NCT00319865 PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT00317408 Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma Status UNKNOWN Phase NA
NCT00316927 Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00314743 Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation Status COMPLETED Phase EARLY_PHASE1
NCT00308594 Oral Dexamethasone for the Treatment of Cervical Radiculopathy Status TERMINATED Phase PHASE2